Skip to main content

Lumify FDA Approval History

Last updated by Judith Stewart, BPharm on May 1, 2024.

FDA Approved: Yes (First approved December 22, 2017)
Brand name: Lumify
Generic name: brimonidine tartrate
Dosage form: Ophthalmic Solution
Company: Bausch & Lomb Inc.
Treatment for: Eye Redness

Lumify (brimonidine tartrate) is an over-the-counter (OTC) formulation of the alpha-adrenergic agonist brimonidine indicated for use in the treatment of ocular redness.

Development timeline for Lumify

Apr 26, 2024Approval Bausch + Lomb Receives FDA Approval of Lumify Preservative Free Redness Reliever Eye Drops
Dec 22, 2017Approval Bausch + Lomb Receives FDA Approval of Lumify (brimonidine tartrate) Over-the-Counter Eye Drop for the Treatment of Eye Redness

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.